Well, things escalated quickly. Which teams made the best -- and worst -- moves before the NFL trade deadline? We're making ...

Delivers Q4 Revenue of $1.10 BillionPosts GAAP Diluted EPS of $0.94 and Non-GAAP Diluted EPS of $1.76Generates Annual Operating Cash Flow of $1.30 Billion and Annual Free Cash Flow of $1.11 Billion ...

Aurinia Pharmaceuticals Inc (AUPH) reports significant growth in Lupkynis sales and raises its 2025 sales guidance, while navigating legal and regulatory hurdles.